$4.83 0.00 (0.00%) Osiris Therapeutics Inc - NASDAQ

Sep. 28, 2016 | 04:00 PM
Last Trade: 4.83
Trade Time: Sep 28 04:00 PM Eastern Daylight Time
Change: +0.00 (0.00%)
Prev Close: 4.83
Open: 4.74
Bid: 4.56
Ask: 5.98
  1. No results found.
  1. Benzinga's Top Downgrades

    Benzinga | Nov. 17, 2015 | 09:26AM EST
  2. Osiris Evaluates the Establishment Of An International Subsidiary

    Benzinga | May. 21, 2015 | 16:32PM EST
  3. Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest Profit Margin

    Benzinga | Feb. 9, 2015 | 04:35AM EST
  4. Celleration Acquisition Just the Start of Alliqua's M&A Strategy

    GuruFocus | Feb. 4, 2015 | 14:18PM EST
  5. Benzinga's Volume Movers

    Benzinga | Dec. 31, 2014 | 10:35AM EST
  6. Brean Capital Initiates Coverage On Osiris Therapeutics

    Benzinga | Dec. 29, 2014 | 17:05PM EST
  7. Osiris Announces a Strategic Partnership with Stryker for Marketing Osiris' Viable Bone Matrix

    Benzinga | Dec. 22, 2014 | 16:31PM EST
  8. Osiris Stem Cells To Compliment Mannkind's Afrezza In Disrupting Diabetes Market

    GuruFocus | Jul. 29, 2014 | 17:50PM EST
  9. Journal Publishes Grafix Clinical Study for Chronic Wounds

    Benzinga | Dec. 18, 2013 | 08:37AM EST
  10. Osiris Therapeutics Reports CMS Decides to Package Reimbursement for Products Used in Advanced Wound Care with the Related Surgical Procedure into Two-Tier System

    Benzinga | Nov. 29, 2013 | 11:33AM EST
  11. Osiris Therapeutics Says Trial on Grafix Met All Primary, Secondary Endpoints

    Benzinga | Nov. 19, 2013 | 14:32PM EST
  12. Market Wrap for Monday, October 21: Dow Closes Down, S&P and Nasdaq Close Up

    Benzinga | Oct. 21, 2013 | 16:15PM EST
  13. Mid-Afternoon Market Update: JC Penney Falls on Massive Volume Following Imperial Capital Price Target

    Benzinga | Oct. 21, 2013 | 15:29PM EST
  14. Osiris Legal Team Responds, Says Reviewing All of Legal-Regulatory Options, Calls TheStreet Story 'Misleading'

    Benzinga | Oct. 21, 2013 | 15:01PM EST
  15. Mid-Day Market Update: Hasbro Surges On Upbeat Earnings; Gannett Shares Tumble

    Benzinga | Oct. 21, 2013 | 12:51PM EST
Trading Center